Zeria Pharmaceutical Co., Ltd. (4559.T) JPX
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In JPY
Address
10-11 Nihonbashi Kobuna-cho
Tokyo, TK 103-8351
Japan
Phone
81 3 3663 2351
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1746
First IPO Date
January 01, 2001
| Name | Title | Pay | Year Born |
| Sachiaki Ibe | Chairman & Chief Executive Officer | 0 | 1941 |
| Yuuki Okazawa | Managing Executive Officer, Director of Administrative & Personnel and Director | 0 | 1965 |
| Kenichi Suzuki | Executive Officer and GM of Corporate Planning Division & Corporate Strategy Promotion Division | 0 | N/A |
| Yoshihiro Hiraga | Executive Officer and GM of Research & Development Headquarters, Licensing Office | 0 | 1957 |
| Kazuhiro Akiba | Executive Officer & GM of Pharmaceutical Sales Division | 0 | N/A |
| Kenji Kusano | Executive Officer & GM of Consumer Healthcare Sales Division | 0 | 1963 |
| Mitsuru Iwai | Executive Officer & GM of Production & Logistics Headquarters | 0 | N/A |
| Hiroki Kato | Managing Executive Officer and GM of Asian Business, Planning Department & Business Development | 0 | 1963 |
| Mitsuhiro Ibe | President, Chief Operating Officer & Representative Director | 0 | 1971 |
| Toshiaki Kawagoe | Executive Officer and GM of Reliability Assurance Headquarters & Customer Relations Office | 0 | 1961 |
| Yasuhisa Tanaka | Executive Officer and GM of Finance & Accounting Division | 0 | N/A |
Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally. The company operates through Ethical Pharmaceuticals Business and Consumer Healthcare Business segments. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company also offers products in the gastrointestinal field, including therapeutic agents for functional dyspepsia, ulcerative colitis, Crohn’s disease, and gastritis and ulcers; zinc containing anti-ulcerants; oral bowel cleansing agents; laxatives; therapeutic agents for hypophosphatemia, and iron deficiency anemia; long-acting calcium channel blockers; oral NSAID; anti-leukopenia after radiotherapy products; and non-steroidal anti-inflammatory ophthalmic solutions. In addition, it provides consumer healthcare products, such as nutritional health drugs, remedies for gastrointestinal diseases, western herbal medicines, cold remedies, ophthalmic solutions, anti-inflammatory/analgesics, hemorroidal remedies, dermal remedies, quasi-drugs/cosmetics, nutrient tonics, soft drinks/health foods, and food for specified health uses. Further, the company engages in insurance agency and real estate business. The company was formerly known as Zeria Yakusho Kenkyusho Co., Ltd. and changed its name to Zeria Pharmaceutical Co., Ltd. in May 1970. Zeria Pharmaceutical Co., Ltd. was incorporated in 1955 and is headquartered in Tokyo, Japan.